The Bichat–Claude Bernard Hospital is located in the 18th arrondissement of Paris, France, and is operated by Assistance Publique – Hôpitaux de Paris. It was founded in 1881 as l'Hôpital Bichat, incorporating the units of nearby Hôpital Claude-Bernard upon the latter's demolition in 1970.

During the past decade, Hopital Bichat Claude Bernard; Nephrologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Bichat Claude Bernard; Nephrologie" are "Lupus Nephritis" (2 trials), "Anemia" (1 trials) and "Primary Membranous Nephropathy" (1 trials). Many other conditions were trialed in "Hopital Bichat Claude Bernard; Nephrologie" in a lesser frequency.

Most popular intervention types in "Hopital Bichat Claude Bernard; Nephrologie" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methylprednisolone" (3 trials), "Obinutuzumab" (3 trials), "Acetaminophen" (2 trials), "Diphenhydramine" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bichat Claude Bernard; Nephrologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Bichat Claude Bernard; Nephrologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Bichat Claude Bernard; Nephrologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bichat Claude Bernard; Nephrologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".